Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Rxi Pharmaceuticals (RXII)

2.34 -0.24 (-9.3%)

05-21 16:00

Open:

2.54

Pre. Close:

2.58

High:

2.566

Low:

2.31

Volume:

326,094

Market Cap:

10M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.576 - 2.589

2.589 - 2.599

Low:

2.278 - 2.294

2.294 - 2.306

Close:

2.318 - 2.342

2.342 - 2.361

Technical analysis  (as of: 2018-05-21 4:33:12 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 2.93     One year: 3.38

Support:

Support1: 1.90    Support2: 1.58

Resistance:

Resistance1: 2.51    Resistance2: 2.89

Pivot:

2.39

Moving Averages:

MA(5): 2.40     MA(20): 2.45

MA(100): 3.48     MA(250): 4.87

MACD:

MACD(12,26): -0.15     Signal(12,26,9): -0.20

%K %D:

%K(14,3): 58.74     %D(3): 58.78

RSI:

RSI(14): 42.82

52-Week:

High: 7.7  Low: 1.9  Change(%): -60.0

Average Vol(K):

3-Month: 45104  10-Days 68616

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RXII has closed above bottom band by 40.8%. Bollinger Bands are 63.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to RXII's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-21T10:00:00-04:00
Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma's Gene Therapy Data

2018-05-18T13:00:12-04:00
RXi Pharma's Samcyprone successful in mid-stage wart study; shares ahead 10%

2018-05-18T11:58:00-04:00
RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with Samcyprone(TM) for the Treatment of Common Warts

2018-05-12T23:28:11-04:00
RXI Pharmaceuticals' (RXII) CEO Geert Cauwenbergh on Q1 2018 Results - Earnings Call Transcript

2018-05-11T12:02:27-04:00
Key events next week - healthcare

2018-05-11T09:19:33-04:00
Premarket Gainers as of 9:05 am (05/11/2018)

2018-05-11T07:41:11-04:00
RXi Pharmaceuticals inks deal with Iovance Biotherapeutics to study its RNAi technology for the advancement of immuno-oncology therapeutics

2018-05-11T07:05:00-04:00
RXi Pharmaceuticals Enters into Material Transfer Agreement with Iovance Biotherapeutics to Study its Self-Delivering RNAi Technology for the Advancement of Immuno-Oncology Therapeutics with Iovance's Tumor Infiltrating Lymphocytes (TILs) for Solid Tumors

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

4.26

Shares Float (M)

3.05

% Held by Insiders

49.80

% Held by Institutions

32.80

Shares Short (K)

387

Shares Short Prior Month (K)

1690

Stock Financials

EPS

-3.940

EPS Est. Current Year

-1.770

EPS Est. Next Year

-0.570

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

5.200

PEG Ratio

Profit Margin

Operating Margin

-62440.00

Return on Assets (ttm)

-142.4

Return on Equity (ttm)

-271.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.164

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.51

Levered Free Cash Flow (M)

-6.00

atoplab.com

Valuation

P/E

-0.59

P/E Growth Ratio

-0.09

P/BV

0.45

P/S

996840000.00

P/CF

-1.05

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2018-01-08

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.